{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Malvern",
      "state": "PA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90877",
      "recalling_firm": "ALMIRALL, LLC",
      "address_1": "101 Lindenwood Dr Ste 400",
      "address_2": "N/A",
      "postal_code": "19355-1769",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-1549-2022",
      "product_description": "Xolegel (ketoconazole) gel 2%, 45 gram tubes, Rx only, Manufactured by: DPT Laboratories, San Antonio, TX 78215, NDC 16110-080-45",
      "product_quantity": "5,315 tubes",
      "reason_for_recall": "Failed Viscosity specification: Slightly higher OOS results obtained for viscosity",
      "recall_initiation_date": "20220916",
      "center_classification_date": "20220929",
      "termination_date": "20230713",
      "report_date": "20221005",
      "code_info": "Lot #: RGAF, Exp. Date 12/2022"
    }
  ]
}